Last updated 2026-08-22
- Raised $200k grant led by Israel Innovation Authority, Oct 2024
- Raised $100k grant led by Coller Capital, Jul 2022
- Raised $1.9M Pre-Seed round led by Jeremy Coller Foundation, Jan 2022
Total raised
$2.2M
Last: Undisclosed Round 2025-02
Stage
Seed
Founded
2021
Headcount
1-10
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
Symbiosis C.M. is an innovative medical device company dedicated to solving anatomical variability in valvular heart disease, allowing better fit and better performance for existing medical devices, as well as standalone products for anatomies with great inter-patient variability.
Symbiosis first product is ValSync, the first minimally invasive personalized solution for valve replacement.
Funding history · 4 rounds · $2.2M total
4 events/rounds · $2.2M Total Funding: $1.9M in Private Equity
Oct 2024
★ Israel Innovation AuthorityJeremy Coller Foundation
Jan 2023
★ Jeremy Coller Foundation
Jul 2022
Jan 2022
Pre-Seed
$1.9M
pitchbook.com
★ Jeremy Coller Foundation
Headcount over time
18 employees (2026-09) · 1 point
Offices
Petah Tikva, Israel · HQ / main office
Q&A
- What is Symbiosis C.M.'s primary focus?
- Symbiosis C.M. is an innovative medical device company focused on solving anatomical variability in valvular heart disease to improve the fit and performance of existing medical devices and develop standalone products for highly variable anatomies.
- What is Symbiosis C.M.'s flagship product?
- Symbiosis C.M.'s first product is ValSync, which is described as the first minimally invasive personalized solution for valve replacement.
- When was Symbiosis C.M. founded?
- Symbiosis C.M. was founded in February 2021.
- How many employees does Symbiosis C.M. have?
- Symbiosis C.M. has 11-50 employees.
- What is Symbiosis C.M.'s current funding stage?
- Symbiosis C.M. is currently in the Seed funding stage.
- Has Symbiosis C.M. received any grants recently?
- Yes, Symbiosis C.M. received a Grant in December 2024 and another in May 2023.
- Who is the Founder & CEO of Symbiosis C.M.?
- Shira Burg is the Founder & CEO of Symbiosis C.M.
- What is the primary sector of Symbiosis C.M.?
- Symbiosis C.M.'s primary sector is Health Tech & Life Sciences.
- Does Symbiosis C.M. hold any patents?
- Yes, Symbiosis C.M. holds one patent.
Team · 8
Shira Burg
Founder · Founder & CEO
Amir Weisberg
Angel investor and seasoned entrepreneur
Prof. Marc Gillinov
Advisor
Stanton Rowe
Advisor
Prof. Ole De Backer
Advisor
Prof. Erez Kachel
Advisor
Prof. David Meerkin
Advisor
Prof. Sa’ar Minha
Advisor
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Highlights
1 PatentsVerified
Tags
valvescardiologyminimally-invasivemedical-devicesheart-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | symbiosis-cm.com/ |
|---|---|
| linkedin.com/company/82605253 |
Identifiers & details
| Legal name | SYMBIOSIS C.M. LTD |
|---|---|
| Former names | Vallus |
| Founded | 2021-2 |
| Employees (exact) | 18 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | symbiosis-cm.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516348679 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-02-22 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 7 — shares_capital (2), other (1), people (2), annual_report (2) |
| Registered address | הסיבים 18 פתח תקווה |
Recent registry events
| Date | Event |
|---|---|
| 2026-05-31 | הקצאת מניות |
| 2026-05-26 | שינוי בתקנון |
| 2026-05-25 | הגדלה של הון רשום |
| 2026-06-11 | עדכון דירקטורים-הוספת דירקטור |
| 2026-06-09 | עדכון בעלי תפקידים |
| 2026-01-06 | דו~ח שנתי-הפחתת הון מוקצה |
| 2026-01-06 | דו~ח שנתי-הקצאת מניות |